GlassScriptPhysician profile
Esli Vaughn
NPI 1447796214
$5,682.68
in general payments reported to CMS, 2019-2025
45 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,194 · 2022: $1,516 · 2023: $2,444 · 2024: $404 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502 · Travel and Lodging: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,502.37 |
| Travel and Lodging | $470.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $683.75 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $628.46 | 2021-2024 | |
| Medtronic, INC. | $617.35 | 2021-2024 | Synchromedii, Vanta Adaptivestim |
| Protega Pharmaceutials INC | $356.05 | 2022-2023 | Roxybond |
| Collegium Pharmaceutical, INC. | $342.20 | 2021-2023 | Belbuca, Xtampza |
| Biohaven Pharmaceuticals, INC. | $293.43 | 2021 | |
| Scilex Pharmaceuticals INC. | $283.13 | 2021-2023 | Ztlido |
| Nevro Corp. | $263.03 | 2022-2023 | Senza |
| Relievant Medsystems, INC. | $229.44 | 2023 | Intracept |
| Biohaven Pharmaceutical Holding Company LTD. | $152.76 | 2022 | |
| Tersera Therapeutics LLC | $152.71 | 2021-2024 | Prialt |
| Grt US Holding, INC. | $148.51 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.92 | 2021-2023 | Relistor |
| Pacira Therapeutics, INC. | $112.69 | 2021 | |
| Abiomed | $96.84 | 2024 | Impella |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esli Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.